Reference
Asif S, et al. Early discontinuation of abiraterone acetate/prednisone (AA/P) in localized prostate cancer. Journal of Clinical Oncology 40 (Suppl. 1): (plus poster) abstr. e17003, No. 16, Jun 2022. Available from: URL: https://ascopubs.org/doi/pdf/10.1200/JCO.2022.40.16_suppl.e17003 [abstract]
Rights and permissions
About this article
Cite this article
Abiraterone acetate/prednisone. Reactions Weekly 1924, 15 (2022). https://doi.org/10.1007/s40278-022-23368-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-022-23368-1